In this episode, Ethel D. Weld, MD, PhD, demonstrates the use of HIV-ASSIST, a free, online, decision support tool to inform ART selection. Ethel D. Weld, MD, PhD Assistant Professor of Medicine , Pharmacology, & Molecular Sciences Division of Clinical Pharmacology Department of Infectious Diseases Johns Hopkins University School of Medicine Attending Physician Inpatient HIV Service General Infectious Diseases Consult Services Johns Hopkins Hospital Baltimore, Maryland Content based on a CME...
May 18, 2021•42 min•Ep. 50
In episode 3 of an ongoing series of sharing sessions between a physician and patient, Jordan J. Feld, MD, MPH, and Wendy, who is living with chronic hepatitis B, discuss the challenges of determining the best time to start treatment. The conversation focuses on incorporating shared decision-making, particularly for cases that are not straight forward and do not fit into an one specific category outlined by the guidelines. Presenter: Jordan J. Feld, MD, MPH Associate Professor of Medicine Univer...
May 11, 2021•18 min•Ep. 49
In this episode, William R. Short, MD, MPH, AAHIVS, discusses current guidelines and clinical trial data informing optimal selection of first-line antiretroviral therapy for HIV. William R. Short, MD, MPH, AAHIVS Associate Professor of Medicine Division of Infectious Diseases Department of Medicine Perelman School of Medicine at the University of Pennsylvania Philadelphia, Pennsylvania Content based on a CME program supported by an independent educational grant from ViiV Healthcare. Link to full...
May 07, 2021•22 min•Ep. 48
In Part 4 of this 4-part series, listen to Howard Grossman, MD, and Cristina Mussini, MD, answer healthcare professionals’ questions on vaccine recommendations, bone health and fragility fractures, and racial disparities and social determinants that affect caring for patients aging with HIV. Presenters: Howard Grossman, MD Clinical Affiliate Assistant Professor Department of Integrated Medical Science Charles E. Schmidt College of Medicine Florida Atlantic University Boca Raton, Florida Medical ...
May 03, 2021•38 min•Ep. 47
In this episode, Drs José R. Arribas, Andrew Carr, and Lynora Saxinger discuss simplification strategies for a virologically suppressed patient with HIV and a complex ART treatment history. Presenters: José R. Arribas, MD Research Director , HIV and Infectious Diseases Hospital La Paz IdiPAZ Madrid, Spain Andrew Carr, MBBS, MD, FRACP, FRCPA Professor of Medicine University of New South Wales Director , HIV and Immunology Unit St Vincent’s Hospital Sydney, Australia Lynora Saxinger, MD, FRCPC, CT...
Apr 27, 2021•19 min•Ep. 46
In this episode, Drs José R. Arribas, Andrew Carr, and Lynora Saxinger discuss ART safety and management in a woman who wishes to conceive. Presenters: José R. Arribas, MD Research Director , HIV and Infectious Diseases Hospital La Paz IdiPAZ Madrid, Spain Andrew Carr, MBBS, MD, FRACP, FRCPA Professor of Medicine University of New South Wales Director , HIV and Immunology Unit St Vincent’s Hospital Sydney, Australia Lynora Saxinger, MD, FRCPC, CTropMed Cochair , Scientific Advisory Group Alberta...
Apr 26, 2021•9 min•Ep. 45
In this episode, Drs José R. Arribas, Andrew Carr, and Lynora Saxinger discuss weight gain concerns for a patient with initiating ART. Presenters: José R. Arribas, MD Research Director , HIV and Infectious Diseases Hospital La Paz IdiPAZ Madrid, Spain Andrew Carr, MBBS, MD, FRACP, FRCPA Professor of Medicine University of New South Wales Director , HIV and Immunology Unit St Vincent’s Hospital Sydney, Australia Lynora Saxinger, MD, FRCPC, CTropMed Cochair , Scientific Advisory Group Alberta COVI...
Apr 23, 2021•17 min•Ep. 44
In episode 2 of an ongoing series of sharing sessions between a physician and patient, Robert Gish, MD, FAASLD, and patient advocate, Alan Wang, discuss stigma as a barrier to optimal HBV care and treatment. The conversation focuses on how stigma affected Alan’s engagement with his care and strategies to overcome stigma as a barrier to HBV care. Presenter: Robert Gish, MD, FAASLD Medical Director Hepatitis B Foundation Medical Director Asian Pacific Health Foundation San Diego, California Conten...
Apr 12, 2021•18 min•Ep. 43
In episode 1 of this ongoing series, listen to a conversation between Grace LH Wong, MD, and her patient, Ms. Chan, on the shared decision for Ms. Chan to start treatment for hepatitis B infection during her pregnancy. Presenter: Grace LH Wong, MD Professor Division of Gastroenterology and Hepatology Department of Medicine and Therapeutics The Chinese University of Hong Kong Honorary Consultant Division of Gastroenterology and Hepatology Department of Medicine and Therapeutics Prince of Wales Ho...
Mar 26, 2021•10 min•Ep. 42
In this episode, Chloe Orkin, MBChB, FRCP, MD, discusses exciting new HIV data reported at the virtual CROI 2021, including new findings on HIV PrEP, HIV and COVID-19, ART in pregnancy and the postpartum period, as well as on the comparative efficacy of various ARV regimens. Presenter: Chloe Orkin, MBChB, FRCP, MD Professor of HIV Queen Mary University of London Consultant Physician Lead for HIV Research Barts Health NHS Trust The Royal London Hospital London, United Kingdom Content based on a C...
Mar 18, 2021•42 min•Ep. 41
In episode 17 of this series, Arthur Kim, MD, provides a brief update on the latest COVID-19 treatment options and guidelines. After the update, Dr. Kim answers questions submitted by healthcare professionals on various aspects of COVID-19. Presenter: Arthur Kim, MD Associate Professor Department of Medicine Harvard Medical School Director , Viral Hepatitis Clinic Division of Infectious Diseases Massachusetts General Hospital Boston, Massachusetts Content based on an online CME program supported...
Mar 09, 2021•37 min•Ep. 40
In this episode, Dr. Bekker discusses results from key studies reported at the 4th HIV Research for Prevention Conference (HIVR4P // Virtual), including results from studies evaluating novel approaches to HIV prevention such as broadly neutralizing antibodies, long-acting injectable and oral ARVs, and implantable options. In addition, Dr. Bekker will discuss several studies evaluating different aspects of PrEP implementation and acceptance as well as considerations for multipurpose prevention st...
Feb 18, 2021•38 min•Ep. 39
In this episode, Dr. Jens Lundgren discusses results from key studies reported at the IAS COVID-19 Conference: Prevention, including new findings on potential SARS-CoV-2 suppressive therapies, strategies for vaccination and mass testing, and interventions to prevent transmission of COVID-19 while maintaining desired outcomes in HIV care. Jens D. Lundgren, MD, DMSc Professor Rigshospitalet, University of Copenhagen Copenhagen, Denmark Director Centre of Excellence for Health, Immunity and Infecti...
Feb 18, 2021•39 min•Ep. 38
In this episode, Part 16 of an ongoing series, Sharon R. Lewin, AO, FRACP, PhD, FAHMS, provides a brief update on emerging COVID-19 variants and their potential impacts on vaccine efficacy. After the update, Professor Lewin answers questions submitted by healthcare professionals on various aspects of COVID-19. Presenter: Sharon R. Lewin, AO, FRACP, PhD, FAHMS Director , The Peter Doherty Institute for Infection and Immunity Melbourne Laureate Professor of Infectious Diseases University of Melbou...
Feb 12, 2021•38 min•Ep. 37
In this episode, Part 3 of a 4-part series, Dr. Monica Gandhi, Dr. Rajesh Gandhi, and Dr. Josep Llibre discuss key health challenges faced by aging patients with HIV and answer clinicians’ questions on HIV treatment considerations and on prevention, screening, and treatment of common age-related comorbidities. Presenters: Monica Gandhi, MD, MPH Professor of Medicine Division of HIV, Infectious Diseases, and Global Medicine University of California, San Francisco Medical Director Ward 86 HIV Clin...
Feb 10, 2021•37 min•Ep. 36
In this episode, Part 15 of an ongoing series, Roger Paredes, MD, PhD, provides a brief update on emerging COVID-19 variants and their potential impacts on the pandemic. After the update, Dr. Paredes answers clinician questions on various aspects of COVID-19. Presenter: Roger Paredes, MD, PhD Section Chief , Infectious Diseases Department Germans Trias i Pujol University Hospital Head of the Microbial Genomics Group IrsiCaixa AIDS Research Institute Badalona, Catalonia, Spain Content based on an...
Jan 25, 2021•42 min•Ep. 35
In this episode, Part 14 of an ongoing series, Vikramjit Mukherjee, MD, provides a brief update on COVID-19 mortality trends, including the latest data on overall and in-hospital fatality rates. After the update, Dr. Mukherjee answers clinician questions on various aspects of COVID-19. Presenter: Vikramjit Mukherjee, MD Assistant Professor of Medicine Division of Pulmonary, Critical Care, and Sleep Medicine New York University School of Medicine Director , Medical Intensive Care Unit Bellevue Ho...
Dec 31, 2020•39 min•Ep. 34
In this episode, Joseph J. Eron, Jr., MD; and Daniel R. Kuritzkes, MD; discuss evolving issues in first-line antiretroviral therapy, including 2-drug therapy, weight gain, and safety during conception and pregnancy. Presenters: Joseph J. Eron, Jr., MD Professor of Medicine and Epidemiology University of North Carolina School of Medicine Director , AIDS Clinical Trials Unit University of North Carolina Chapel Hill, North Carolina Daniel R. Kuritzkes, MD Chief , Division of Infectious Diseases Bri...
Dec 29, 2020•31 min•Ep. 33
In this episode, the third in a 3-part series on Ending the HIV Epidemic, Judith Feinberg, MD, and Kenneth Mayer, MD, discuss the important role of HIV pre-expsoure prophylaxis (PrEP) for preventing HIV infection among at-risk individuals and critical strategies for effective PrEP implementation among principle populations, including men who have sex with men and transgender women, heterosexual cisgender women, and people who inject drugs. Following their dialogue, the faculty field clinician qu...
Dec 24, 2020•37 min•Ep. 32
In this episode, Roger Bedimo, MD, MS, FACP, and Eric S. Daar, MD, discuss caring for heavily treatment–experienced patients with HIV, including assessment of virologic failure and current treatment options for patients with multiclass drug resistance. Presenters: Roger Bedimo, MD, MS, FACP Professor of Medicine Division of Infectious Diseases University of Texas Southwestern Medical Center Section Chief Division of Infectious Diseases Department of Internal Medicine VA North Texas Health Care S...
Dec 18, 2020•32 min•Ep. 31
In this episode, Part 13 of an ongoing series, Jens D. Lundgren, MD, DMSc, provides a brief update monoclonal antibody treatments for COVID-19, including the FDA Emergency Use Authorization for bamlanivimab and discusses the recently released information on COVID-19 vaccine efficacy. After the update, Professor Lundgren answers clinician questions on various aspects of COVID-19. Presenter: Jens D. Lundgren, MD, DMSc Professor Rigshospitalet, University of Copenhagen Copenhagen, Denmark Director ...
Dec 08, 2020•38 min•Ep. 29
In this episode, the second in a 3-part series on Ending the HIV Epidemic, Jason Halperin, MD, MPH, and Aadia I. Rana, MD, discuss treatment as prevention, the critical infrastructure needed to implement rapid ART, the importance of routinely assessing for barriers to care, and real-time monitoring strategies that improve patient adherence and engagement. Following their dialogue, the faculty field clinician questions on HIV treatment and retention in care. Presenters: Jason Halperin, MD, MPH As...
Dec 08, 2020•41 min•Ep. 30
In this episode, Dr. Terrault discusses results from key viral hepatitis studies reported at the American Association for the Study of Liver Diseases (AASLD) 2020 annual conference, The Liver Meeting Digital Experience, including new findings on HBV treatment and management, hepatocellular carcinoma risk, and emerging approaches to HCV care in underserved populations. Presenter: Norah Terrault, MD, MPH Professor of Medicine Chief of Gastrointestinal and Liver Diseases University of Southern Cali...
Nov 25, 2020•50 min•Ep. 28
In this episode, Brian Wood, MD, discusses HIV treatment safety and tolerability data from 2020 conferences and addresses how he manages ARV-associated weight gain his patients and how the latest data on ART safety during conception and pregnancy impact his treatment recommendations. Presenters: Brian Wood, MD Associate Professor of Medicine Division of Allergy and Infectious Diseases University of Washington Seattle, Washington Content based on an online CME/CE/CPE-certified program supported b...
Nov 23, 2020•34 min•Ep. 27
In this episode, Part 2 of an 4-part series, Dr. Jonathan Appelbaum, Dr. Howard Grossman, and Professor Jürgen Rockstroh discuss key health challenges faced by aging patients with HIV and answer clinicians’ questions on HIV treatment considerations and on prevention, screening, and treatment of common age-related comorbidities. Presenters: Jonathan Appelbaum MD, FACP, AAHIVS Laurie L. Dozier Jr, MD, Education Director Professor of Medicine Chair , Department of Clinical Sciences Florida State Un...
Nov 19, 2020•40 min•Ep. 26
In this episode, Dr. Joseph Eron and Dr. Jason Halperin discuss caring for complex HIV cases, including patients with underlying resistance or comorbidities. Presenters: Joseph J. Eron, Jr., MD Professor of Medicine and Epidemiology University of North Carolina School of Medicine Director , AIDS Clinical Trials Unit University of North Carolina Chapel Hill, North Carolina Jason Halperin, MD, MPH Assistant Professor of Medicine Department of Infectious Diseases Tulane University Infectious Diseas...
Nov 17, 2020•42 min•Ep. 25
In this episode, Part 12 of an ongoing series, David Heymann, BA, MD, DTM&H, provides a brief update on strategies for moving forward and living safely within the continued COVID-19 pandemic. After the update, Professor Heymann answers clinician questions on various aspects of COVID-19. Presenter: David Heymann, BA, MD, DTM&H Professor of Infectious Disease Epidemiology London School of Hygiene & Tropical Medicine London, England Content based on an online CME program supported by an...
Nov 09, 2020•41 min•Ep. 24
In this episode, the first in a 3-part series on Ending the HIV Epidemic, Lisa K. Fitzpatrick, MD, MPH, MPA, and David Malebranche, MD, MPH, discuss strategies to expand early HIV testing, maximize patient engagement in HIV care, navigate emerging clusters of HIV infection, and combat HIV-related stigma. Following their dialogue, the faculty field clinician questions on HIV diagnosis and management. Presenters: Lisa K. Fitzpatrick, MD, MPH, MPA Professorial Lecturer Department of Epidemiology Ge...
Nov 04, 2020•50 min•Ep. 22
In this episode, Dr. Gandhi discusses results from key studies reported at the virtual IDWeek 2020 conference, including new findings on transmission in different settings, symptom progression and clinical outcomes, detection of non-SARS-CoV-2 viruses during the pandemic, and treatment and prevention strategies. Presenter: Rajesh T. Gandhi, MD Professor of Medicine Department of Infectious Diseases Harvard Medical School Physician, Infectious Diseases Massachusetts General Hospital Boston, Massa...
Oct 30, 2020•40 min•Ep. 23
In this episode, Part 11 of an ongoing series, Sharon R. Lewin AO, FRACP, PhD, FAHMS, provides a brief update on the role of interferons in COVID-19. After the update, Dr. Lewin answers clinician questions on various aspects of COVID-19. Presenter: Sharon R. Lewin AO, FRACP, PhD, FAHMS Director , The Peter Doherty Institute for Infection and Immunity Melbourne Laureate Professor of Infectious Diseases University of Melbourne Consultant Infectious Diseases Physician Alfred Hospital and Royal Melb...
Oct 29, 2020•32 min•Ep. 21
